155 related articles for article (PubMed ID: 25268778)
1. Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
de Morais TL; Giribela C; Nisenbaum MG; Guerra G; Mello N; Baracat E; Consolim-Colombo FM
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():113-7. PubMed ID: 25268778
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
3. Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial.
Nisenbaum MG; de Melo NR; Giribela CR; de Morais TL; Guerra GM; de Angelis K; Mostarda C; Baracat EC; Consolim-Colombo FM
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():62-6. PubMed ID: 24480113
[TBL] [Abstract][Full Text] [Related]
4. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Giribela CR; Consolim-Colombo FM; Nisenbaum MG; Moraes TL; Giribela AH; Baracat EC; Melo NR
Gynecol Endocrinol; 2015; 31(11):912-5. PubMed ID: 26172927
[TBL] [Abstract][Full Text] [Related]
5. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
7. Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial.
de Nadai MN; Nobre F; Ferriani RA; Vieira CS
Blood Press Monit; 2015 Dec; 20(6):310-5. PubMed ID: 26154851
[TBL] [Abstract][Full Text] [Related]
8. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
[TBL] [Abstract][Full Text] [Related]
9. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
Oelkers W; Helmerhorst FM; Wuttke W; Heithecker R
Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282
[TBL] [Abstract][Full Text] [Related]
10. Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study.
Cagnacci A; Ferrari S; Napolitano A; Piacenti I; Arangino S; Volpe A
Contraception; 2013 Sep; 88(3):413-7. PubMed ID: 23312932
[TBL] [Abstract][Full Text] [Related]
11. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
12. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Anttila L; Kunz M; Marr J
Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
[TBL] [Abstract][Full Text] [Related]
13. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
14. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
Kluft C; Endrikat J; Mulder SM; Gerlinger C; Heithecker R
Contraception; 2006 Apr; 73(4):336-43. PubMed ID: 16531162
[TBL] [Abstract][Full Text] [Related]
16. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Duijkers IJ; Klipping C; Grob P; Korver T
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):314-25. PubMed ID: 20695770
[TBL] [Abstract][Full Text] [Related]
17. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration.
Ahmed AH; Gordon RD; Taylor PJ; Ward G; Pimenta E; Stowasser M
J Clin Endocrinol Metab; 2011 Jun; 96(6):1797-804. PubMed ID: 21411552
[TBL] [Abstract][Full Text] [Related]
18. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Yildizhan R; Gokce AI; Yildizhan B; Cim N
Gynecol Endocrinol; 2015 May; 31(5):396-400. PubMed ID: 25739031
[TBL] [Abstract][Full Text] [Related]
20. The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.
Fruzzetti F; Lello S; Lazzarini V; Fratta S; Orrù M; Sorge R; Minerba L; Ricci C; Genazzani AR; Melis GB; Paoletti AM
Contraception; 2007 Mar; 75(3):199-203. PubMed ID: 17303489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
